Montelukast Sodium Tablet, Chewable
Product Images NDC 63187-896

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 63187-896). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Montelukast Sodium Tablets And Chewable Tablets 1)

Figure 1 (Montelukast Sodium Tablets And Chewable Tablets 1)
This appears to be a table or graph displaying the change in height (measured in centimeters) over a period of time, possibly as a result of various treatments. The three treatments listed are Montelukast Sodium, Beclomethasone, and Placebo, with the number of participants per treatment listed in parentheses. However, the text is incomplete and difficult to interpret accurately, therefore additional context is required to provide a fully useful description.*
FDA Label Image

Chemical Structure (Montelukast Sodium Tablets And Chewable Tablets 2)

FDA Label Image

Figure 2 (Montelukast Sodium Tablets And Chewable Tablets 3)

FDA Label Image

63187-896-30 (Montelukast Sodium Tablets And Chewable Tablets 5)

63187-896-30 (Montelukast Sodium Tablets And Chewable Tablets 5)
Montelukast Sodium 5mg chewable tablets, lot number 00000, are designed for pediatric patients ages 6-14. They are specifically designed to treat asthma and seasonal allergies. The tablets are round, light pink with "KU" on one side and "205" on the other. Each tablet contains 5.2mg of Montelukast Sodium, which is considered equivalent to 5mg of Montelukast. The medication should be stored at 25°C (77°F) and kept out of reach of children. The product was manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc. and packaged by Proficient Rx LP. The National Drug Code is 63187-896-30 and the expiration date is 00/00/00.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.